Company Active LTD

Company profile

Calla Lily Clinical Care Ltd

Innovators in Vaginal Drug Delivery | Calla Lily Clinical Care

Supporting fertility, pregnancy, ahealthy vaginal microbiome and other gynaecological conditions

CRN
13417472
Founded
2021
Age
5

Overview

Legal name
CALLA LILY CLINICAL CARE LTD
Region
London
Registered address
5TH FLOOR CHARLES HOUSE
108-110 FINCHLEY ROAD
LONDON
UNITED KINGDOM
NW3 5JJ
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
12

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

10 Jun
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUyNjE4NDg2OGFkaXF6a2N4

Published 10 Jun 2026 09:53

06 Jun
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

23 May
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

24 May
2021

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2021
Funded years
2021, 2023
Age at first award
0 years

Projects

2023 Collaborative R&D Lead participant

Development of a women-centric gynaecological drug delivery device to improve psychosocial and physical wellbeing during treatment for miscarriage & pre-term birth prevention, and IVF

1 Apr 2023 to 31 Mar 2025

Awarded
£698,823
Total cost £998,318

Calla Lily Clinical Care (CLCC) is an ambitious British startup that has successfully invented a novel hybrid tampon and pantyliner that can be designed in such a way that it delivers drugs to a woman's vagina when in place. The current way of delivering drugs to the vagina is to use a pessary, but these are inconvenient, unhygienic, prone to movement suc...

2021 Feasibility Studies Lead participant

Overcoming pre-clinical challenges for a next-generation gynaecological drug delivery device which maximises patient comfort and convenience

1 Nov 2021 to 31 Oct 2022

Awarded
£349,483
Total cost £499,261

Callaly is an ambitious British startup that has successfully developed and commercialised the first major innovation to the tampon in decades: a novel "hybrid" tampon and pantyliner that is the brainchild of a senior British gynaecologist. Called a Tampliner(R), the already multi award-winning product includes enhanced leakage prevention properties and a...

Product types

Collaborative R&D Feasibility Studies